Lau HK - Search Results

1

Hypofibrinolysis in patients with hypercoagulability: the roles of urokinase and of plasminogen activator inhibitor.

Lau HK, Teitel JM, Cheung T, Kung SK, Garvey MB. Lau HK, et al. Am J Hematol. 1993 Dec;44(4):260-5. doi: 10.1002/ajh.2830440408. Am J Hematol. 1993. PMID: 8237997

2

Plasma urokinase antigen and plasminogen activator inhibitor-1 antigen levels predict angiographic coronary restenosis.

Strauss BH, Lau HK, Bowman KA, Sparkes J, Chisholm RJ, Garvey MB, Fenkell LL, Natarajan MK, Singh I, Teitel JM. Strauss BH, et al. Among authors: lau hk. Circulation. 1999 Oct 12;100(15):1616-22. doi: 10.1161/01.cir.100.15.1616. Circulation. 1999. PMID: 10517732

3

Isolation and characterization of cell lines with reduced urokinase binding.

Lau HK, Teitel JM, Kim M. Lau HK, et al. Clin Exp Metastasis. 2000;18(1):29-36. doi: 10.1023/a:1026521216811. Clin Exp Metastasis. 2000. PMID: 11206835

4

Thrombin-activatable fibrinolysis inhibitor (TAFI): a novel predictor of angiographic coronary restenosis.

Lau HK, Segev A, Hegele RA, Sparkes JD, Teitel JM, Chisholm RJ, Strauss BH. Lau HK, et al. Thromb Haemost. 2003 Dec;90(6):1187-91. doi: 10.1160/TH03-05-0308. Thromb Haemost. 2003. PMID: 14652655

5

Characterization of immunotrap assays for urokinase plasminogen activator and its inhibitors and measurements of these molecules in human plasma and mouse macrophage in culture.

Kung SK, Lau HK. Kung SK, et al. Among authors: lau hk. Int J Biochem. 1993 May;25(5):781-8. doi: 10.1016/0020-711x(93)90365-l. Int J Biochem. 1993. PMID: 8349018

6

Characterization of radioimmunoassays for high- and low-molecular weight urokinases and estimation of different molecular forms of urokinase in urine and plasma.

Cheung T, Lui AY, Lau HK. Cheung T, et al. Among authors: lau hk. J Lab Clin Med. 1993 Mar;121(3):461-71. J Lab Clin Med. 1993. PMID: 8445294

7

Modulation of the plasminogen activation system in murine macrophages.

Kung SK, Lau HK. Kung SK, et al. Among authors: lau hk. Biochim Biophys Acta. 1993 Mar 10;1176(1-2):113-22. doi: 10.1016/0167-4889(93)90185-r. Biochim Biophys Acta. 1993. PMID: 8452867

8

Homocysteine, lipoprotein(a), and restenosis after percutaneous transluminal coronary angioplasty: a prospective study.

Miner SE, Hegele RA, Sparkes J, Teitel JM, Bowman KA, Connelly PW, Banijamali H, Lau HK, Chisholm RJ, Babaei S, Strauss BH. Miner SE, et al. Among authors: lau hk. Am Heart J. 2000 Aug;140(2):272-8. doi: 10.1067/mhj.2000.107546. Am Heart J. 2000. PMID: 10925342

9

Thr325Ile polymorphism of the TAFI gene is related to TAFI antigen plasma levels and angiographic restenosis after percutaneous coronary interventions.

Segev A, Hegele RA, Lau HK, Sparkes JD, Teitel JM, Chisholm RJ, Strauss BH. Segev A, et al. Among authors: lau hk. Thromb Res. 2004;114(2):137-41. doi: 10.1016/j.thromres.2004.06.003. Thromb Res. 2004. PMID: 15306156 Clinical Trial.

10

Discrepancies in measured factor VIII activity in patients treated with factor VIII concentrate of human or porcine origin.

Teitel JM, Lau HK, Garvey MB. Teitel JM, et al. Among authors: lau hk. Thromb Haemost. 2002 Jul;88(1):159-60. Thromb Haemost. 2002. PMID: 12152659 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

107 results

Search Page

Filters